ovarian cancer Archives

US regulator grants fast review for AZ ovarian cancer drug

https://pharmaphorum.com/news/us-regulator-grants-fast-review-for-az-ovarian-cancer-drug/

ESMO round-up: Big win for AstraZeneca in ovarian cancer, and more

https://pharmaphorum.com/views-and-analysis/esmo-round-up-big-win-for-astrazeneca-in-ovarian-cancer-and-more/

AZ/Merck & Co’s Lynparza scores huge ovarian cancer win

https://pharmaphorum.com/news/az-merck-cos-lynparza-scores-huge-ovarian-cancer-win/

FDA says Clovis’ Rubraca could be prostate cancer breakthrough

https://pharmaphorum.com/news/fda-says-clovis-rubraca-could-be-prostate-cancer-breakthrough/

Chinese pharma market primed for growth after sweeping reforms

https://pharmaphorum.com/r-d/views-analysis-r-d/chinese-pharma-market/

J&J hopes to overturn $4.69bn compensation bill

https://pharmaphorum.com/news/jj-hopes-to-overturn-4-69bn-compensation-bill/

AstraZeneca/Merck hope for expanded ovarian cancer drug use

https://pharmaphorum.com/news/astrazeneca-mercks-hope-for-expanded-lynparza/

ASCO 2018 – Tuesday 5th June: Tesaro developing checkpoint combo

https://pharmaphorum.com/views-and-analysis/asco-2018-tesaro-checkpoint-combo/

Clovis’ PARP drug gets new US ovarian cancer use

https://pharmaphorum.com/news/clovis-parp-drug-gets-new-us-ovarian-cancer-use/

Search